Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318532 · ClinicalTrials.gov registry record · NA
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women
A NA study of HIV Prevention Program, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 745
- Enrollment target
- 1
- Study location
NCT07318532 is a NA study of HIV Prevention Program that has completed, run by Medstar Health Research Institute. The registered enrollment target is 745 participants, above the 225-participant average among 3 other HIV Prevention Program trials with a reported enrollment target (231% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07318532, a NA study of HIV Prevention Program, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 745 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the "PrEP CGW" pilot study is evaluate the feasibility and acceptability of a clinic-level intervention to improve HIV prevention and Pre-exposure Prophylaxis (PrEP) services for women. The intervention includes clinic wide trainings, provider and clinic staff tool kits, PrEP navigation, and patient-facing educational resources. The overarching goal of the program is to determine if the intervention improves PrEP uptake among women. Patients who attend the study-site clinic will be exposed to the intervention. Patients will be invited to participate in post-visit questionnaires; approximately 20 patients will be invited to participate in interviews.
Conditions Studied
Interventions
- BEHAVIORAL The women's PrEP Project (W-PrEP)
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 745 participants |
| Start Date | 2023-01-02 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07318532
The ClinicalTrials.gov registry entry for NCT07318532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 745 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 225-participant average among 3 other HIV Prevention Program trials with a reported enrollment target (231% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Prevention Program appearing as the primary indexed condition, and to 1 intervention - of which The women's PrEP Project (W-PrEP) is the first listed.
NCT07318532 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07318532 about?
NCT07318532 is a clinical study titled "Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women". The goal of the "PrEP CGW" pilot study is evaluate the feasibility and acceptability of a clinic-level intervention to improve HIV prevention and Pre-exposure Prophylaxis (PrEP) services for women. The intervention includes clinic wide trainings, provider and clinic staff tool kits, PrEP navigation,...
What is the current status of trial NCT07318532?
This trial is currently completed. It is a NA study. The enrollment target is 745 participants. The study started on 2023-01-02. Estimated completion is 2024-06-30.
What conditions does trial NCT07318532 study?
This clinical trial studies the following conditions: HIV Prevention Program.
What interventions are being tested in trial NCT07318532?
The interventions under investigation include: The women's PrEP Project (W-PrEP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07318532?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318532 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention Program
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
RECRUITING · NA
-
Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program
COMPLETED · NA
-
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.